256 results on '"Neyses L"'
Search Results
2. OC 15 - ENHANCEMENT OF VEGF-MEDIATED ANGIOGENESIS BY INHIBITION OF THE PLASMA MEMBRANE CALCIUM ATPASE 4 PROTEIN WITH AURINTRICARBOXYLIC ACID
- Author
-
Kurusamy, S., Baggott, R., Lopez-maderuelo, D., Little, R., Oceandy, D., Cartwright, E., Rowther, F., Wang, W., Neyses, L., Redondo, J. M., and Armesilla, A. L.
- Published
- 2015
3. Incretins as a novel therapeutic strategy in patients with diabetes and heart failure
- Author
-
Khan, M. A., Deaton, C., Rutter, M. K., Neyses, L., and Mamas, M. A.
- Published
- 2013
- Full Text
- View/download PDF
4. P77Specific consideration when interpreting the hypertrophy response to pressure overload in C57BL/6NTac and C57BL/6J mice
- Author
-
Zi, M, Stafford, N, Prehar, S, Shaheen, M, Oceandy, D, Neyses, L, and Cartwright, E
- Published
- 2014
- Full Text
- View/download PDF
5. PMCA4-mediated signaling in cardiac fibroblasts controls cardiac hypertrophy: 1054
- Author
-
Oceandy, D, Abouleisa, R, Mohamed, T, Zi, M, Prehar, S, Baudoin, F, Cartwright, E, and Neyses, L
- Published
- 2014
6. Global PMCA1 deletion leads to increased blood pressure and left ventricular hypertrophy: 520
- Author
-
Hammad, S K, Zi, M, Prehar, S, Neyses, L, and Cartwright, E J
- Published
- 2014
7. Atrial Fibrillation in Heart Failure: An Innocent Bystander?
- Author
-
Khan, M. A., Neyses, L., and Mamas, M. A.
- Published
- 2012
8. P283The Mammalian Ste20-like kinase 2 (Mst2) modulates pathological hypertrophy by regulating the Raf1-ERK1/2 signalling pathway
- Author
-
Maqsood, A., Zi, M., Prehar, S., Neyses, L., Ray, S., and Oceandy, D.
- Published
- 2012
9. Investigation of the Met-267 Arg exchange in isoform 1 of the human plasma membrane calcium pump in patients with essential hypertension by the amplification-created restriction site technique
- Author
-
Benkwitz, C., Kubisch, C., Kraft, K., and Neyses, L.
- Published
- 1997
- Full Text
- View/download PDF
10. Estrogen effects in the heart
- Author
-
Pelzer, T., Shamim, A., and Neyses, L.
- Published
- 1996
- Full Text
- View/download PDF
11. Diuretic usage in heart failure: a continuing conundrum in 2005
- Author
-
Gupta, S. and Neyses, L.
- Published
- 2005
12. Abstract
- Author
-
Mache, Ch., Urban, Ch., Sauer, H., Brandesky, G., Meßner, H., Grienberger, H., Becker, H., Slave, I., Hauer, Ch., Pakisch, B., Oberbauer, R., Mokry, M., Ebner, F., Kleinert, R., Schiller, D., Kasparu, H., Schneider, G., Sega, W., Lutz, D., Mader, R. M., Steger, G. G., Sieder, A. E., Ovissi, L., Roth, E., Hamilton, G., Jakesz, R., Rainer, H., Schenk, T., Kornek, G., Schulz, F., Depisch, D., Rosen, H., Sebesta, Ch., Scheithauer, W., Locker, G. J., Czernin, J., Derfler, K., Gnant, M., Schiessel, R., Petru, E., Pickel, H., Heydarfadai, M., Lahousen, M., Haas, J., Sagaster, P., Flamm, J., Umek, H., Essl, R., Teich, G., Micksche, M., Ludwig, H., Ambros, P. F., Lestou, V., Strehl, S., Mann, G., Gadner, H., Eibl, B., Greiter, E., Grünewald, K., Gastl, G., Thaler, J., Aulitzky, W., Lion, T., Henn, T., Gaiger, A., Hofmann, J., Wolf, A., Spitaler, M., Ludescher, Christof, Grunicke, H., Mitterbauer, G., Stangl, E., Geissler, K., Jäger, U., Lechner, K., Mannhalter, C., Haas, Oskar A., Tirita, Anthi, Kahls, P., Haas, O., Hinterberger, W., Linkesch, W., Pober, Michael, Fae, Ingrid, Kyrle, Alexander, Neumeister, Andrea, Panzer, Simon, Kandioler, D., End, A., Grill, R., Karlic, H., Inhauser, T., Chott, A., Pirc-Danoewinata, H., Klepetko, W., Heinz, R., Hopfinger-Limberger, G., Koller, E., Schneider, B., Pittermann, E., Lorber, C., Eichinger, S., Neumann, E., Weidinger, J., Gisslinger, H., Bedford P., Jones D., Cawley J., Catovsky D., Bevan P., Scherrer, R., Bettelheim, P., Knöbl, P., Kyrie, P. A., Lazcika, K., Schwarzinger, I., Sillaber, C., Watzke, H., Dávid, M., Losonczy, H., Matolcsy, A., Papp, M., Prischl, F. C., Schwarzmeier, J. D., Zoubek, Andreas, Harbott, Jochen, Ritterbach, Jutta, Ritter, Jörg, Sillaber, Ch., Agis, H., Spanblöchl, E., Sperr, W. R., Valent, P., Czerwenka, K., Virgolini, I., Li, S. R., Müller, M., Wrann, M., Gaggl, S., Fasching, B., Herold, M., Geissler, D., Nachbaur, D., Huber, Ch., Schwaighofer, H., Pichl, M., Niederwieser, D., Gilly, B., Weissel, H., Lorber, Ch., Schwarzmeier, J., Gasché, C., Reinisch, W., Hilgarth, M., Keil, F., Thomssen, C., Kolb, H. J., Holler, E., Wilmanns, W., Tilg, H., Gächter, A., Panzer-Grümayer, E. R., Majdic, O., Kersey, J. H., Petzer, A. L., Bilgeri, R., Zilian, U., Geisen, F. H., Haun, M., Konwalinka, G., Fuchs, D., Zangerle, R., Artner-Dworzak, E., Weiss, G., Fritsch, P., Tilz, G. P., Dierich, M. P., Wachter, H., Schüller, J., Czejka, M. J., Jäger, W., Meyer, B., Weiss, C., Schernthaner, G., Marosi, Ch., Onderka, E., Schlögl, B., Maca, T., Hanak, R., Mannhalter, Ch., Brenner, B., Mayer, R., Langmann, A., Langmann, G., Slave, J., Poier, E., Stücklschweiger, G., Hackl, A., Fritz, A., Pabinger, I., Willfort, A., Groiss, E., Bernhart, M., Waldner, R., Krieger, O., Nowotny, H., Strobl, H., Michlmayr, G., Mistrik, M., lstvan, L., Kapiotis, S., Laczika, K., Speiser, W., Granena, A., Hermans, J., Zwaan, F., Gratwohl, A., Labar B., Mrsić M., Nemet D., Bogdanić V., Radman I., Zupančić-Šalek Silva, Kovačević-Metelko Jasna, Aurer I., Forstinger, C., Scholten, C., Kier, P., Kalhs, P., Schwinger, W., Slavc, I., Lackner, H., Nussbaumer, W., Fritsch, E., Fink, M., Zechner, O., Kührer, I., Kletter, V., Frey, S., Leitgeb, C., Fritz, E., Silly, H., Brezinschek, R., Kuss, I., Stöger, H., Schmid, M., Samonigg, H., Wilders-Truschnig, M., Schmidt, F., Bauernhofer, T., Kasparek, A. K., Ploner, F., Stoeger, H., Moser, R., Leikauf, W., Klemm, F., Pfeffel, F., Niessner, H., Poschauko, H., Pojer, E., Locker, G. J., Braun, J., Gnant, M. F. X., Michl, I., Pirker, R., Liebhard, A., Zielinski, C., Dittrich, C., Bernát, S. I., Pongrácz, E., Kastner, J., Raderer, M., Jorbenyi, Z., Yilmaz, A., Suardet, L., Lahm, H., Odartchenko, N., Varga, Gy., Sréter, L. A., Oberberg, D., Berdel, W. E., Budiman, R., Brand, C., Berkessy, S., Radványi, G., Pauker, Zs., Nagy, Zs., Karádi, Å., Serti, S., Hainz, R., Kirchweger, P., Prager, C., Prada, J., Neifer, S., Bienzle, U., Kremsner, P., Kämmerer, B., Vetterlein, M., Pohl, W., Letnansky, K., Imre, S. G., Parkas, T., Lakos, Zs., Kiss, A., Telek, B., Felszeghy, E., Kelemen, E., Rak, K., Pfeilstöcker, M., Reisner, R., Salamon, J., Georgopoulos, A., Feistauer, S., Georgopoulos, M., Graninger, W., Klinda, F., Hrubisko, M., Sakalova, A., Weißmann, A., Röhle, R., Fortelny, R., Gutierrez, F., Fritsch, G., Printz, D., Buchinger, P., Buchinger, P., Hoecker, P., Peters, C., Gebauer, E., Katanić, D., Nagy, Á., Szomor, Á., Med. J., Batinić D., Užaervić B., Marušić M., Kovačoević-Metelko Jasminka, Jakić-Razumović Jasminka, Kovačević-Metelko Jasminka, Zuoancić-Šalek Silva, Ihra, G. C., Reinisch, W. W., Hilgarth, M. F., Schwarzmeier, I. D., Várady, E., Molnár, Z. S., Fleischmann, T., Borbényi, Z., Bérczi, M., István, L., Szerafin, L., Jakó, J., Bányai, A., Dankó, K., Szegedi, Gy., Neubauer, M., Frudinger, A., Scholten, Ch., Forstinger, Ch., Dobrić I., Willheim, M., Szépfalusi, Z., Mader, R., Boltz, G., Schwarzmeier, J. D., Nahajevszky, S., Téri, N., Póth, I., Nagy, P., Smanykó, D., Babicz, T., Ujj, Gy., Iványi, J. L., Tóth, F. D., Kiss, J., Konja, J., Petković, I., Kardum, I., Kaštelan, M., Kelečić, J., Feminić, R., Djermanović, M., Bilić, E., Jakovljević, G., Peter, B., Gredelj, G., Senji, P., Thalhammer, F., Floth, A., Etele-Hainz, A., Kainberger, F., Radaszkiewicz, T., Kierner, H., Mód, Anna, Pitlik, E., Gottesman, M., Magócsi, Mária, Sarkadi, B., Knapp, S., Purtscher, B., DelleKarth, G., Jaeger, U., Krieger, O., Berger, W., Elbling, L., Ludescher, C., Hilbe, W., Eisterer, W., Preuß, E., Izraeli, S., Janssen, J. W. G., Walther, J. U., Kovar, H., Ludwig, W. D., Rechavi, G., Bartram, C. R., Rehberger, A., Mittermayer, F., Schauer, E., Kokoschka, E. M., Kammerer, B., Kokron, E., Desser, L., Abdul-Hamid, G., Kroschinksky, F., Luther, Th., Fischer, H., Nowak, R., Wolf, H., Fleischer, J., Wichmann, G., Albercht, S., Adorf, D., Kaboth, W., Nerl, C., Aman, J., Rudolf, G., Peschel, C., Anders, O., Burstein, Ch., Ernst, B., Steiner, H., Konrad, H., Annaloro, U. P., Mozzana, C., Butti, R., Della, C., Volpe A., Soligo D., Uderzo M., Lambertenghi-Deliliers G., Ansari, H., Dickson, D., Hasford, J., Hehlmann, R., Anyanwu, E., Krysa, S., Bülzebrück, H., Vogt-Moykopf, I., Arning, M., Südhoff, Th., Kliche, K. O., Wehmeier, A., Schneider, W., Arnold, R., Bunjes, D., Hertenstein, B., Hueske, D., Stefanic, M., Theobald, M., Wiesneth, M., Heimpel, H., Waldmann, H., Arseniev, L., Bokemeyer, C., Andres, J., Könneke, A., Papageorgiou, E., Kleine, H. -D., Battmer, K., Südmeyer, I., Zaki, M., Schmoll, H. -J., Stangel, W., Poliwoda, H., Link, H., Aul, C., Runde, V., Heyll, A., Germing, U., Gattermann, N., Ebert, A., Feinendegen, L. E., Huhn, D., Bergmann, L., Dönner, H., Hartlapp, J. H., Kreiter, H., Schuhmacher, K., Schalk T., Sparwasser C., Peschel U., Fraaß C. Huber, HIadik, F., Kolbe, K., Irschick, E., Bajko, G., Wozny, T., Hansz, J., Bares, R., Buell, U., Baumann, I., Harms, H., Kuse, R., Wilms, K., Müller-Hermelink, H. K., Baurmann, H., Cherif, D., Berger, R., Becker, K., Zeller, W., Helmchen, U., Hossfeld, D. K., Bentrup, I., Plusczyk, T., Kemkes-Matthes, B., Matthes, K., Bentz, M., Speicher, M., Schröder, M., Moos, M., Döhner, H., Lichter, P., Stilgenbauer, S., Korfel, A., Harnoss, B. -M., Boese-Landgraf, J., May, E., Kreuser, E. -D., Thiel, E., Karacas, T., Jahn, B., Lautenschläger, G., Szepes, S., Fenchel, K., Mitrou, P. S., Hoelzer, D., Heil, G., Lengfelder, E., Puzicha, E., Martin, H., Beyer, J., Kleiner, S., Strohscheer, I., Schwerdtfeger, R., Schwella, N., Schmidt-Wolf, I., Siegert, W., Weyer, C., arzen, G., Risse, G., Miksits, K., Farshidfar, G., Birken, R., Schilling, C. v., Brugger, W., Holldack, J., Mertelsmann, R., Kanz, L., Blanz, J., Mewes, K., Ehninger, G., Zeller, K. -P., Böhme. A., Just G., Bergmann. L., Shah P., Hoelzer D., Stille W., Bohlen, H., Hopff, T., Kapp, U., Wolf, J., Engert, A., Diehl, V., Tesch, H., Schrader, A., van Rhee, J., Köhne-Wömpner, H., Bokemeyer', C., Gonnermann, D., Harstrick, A., Schöffski, P., van Rhee, J., Schuppert, F., Freund, M., Boos, J., Göring, M., Blaschke, G., Borstel, A., Franke, A., Hüller, G., Uhle, R., Weise, W., Brach, Marion A., Gruss, Hans-Jürgen, Herrmann, Friedhelm, deVos, Sven, Brennscheidt, Ulrich, Riedel, Detlev, Klch, Walter, Bonlfer, Renate, Mertelsmann, Roland, Brieaer, J., Appelhans, H., Brückner, S., Siemens, HJ., Wagner, T., Moecklin, W., Mertelsmann, R., Bertz, H., Hecht, T., Mertelsmann, R., Bühl, K., Eichelbaum, M. G., Ladda, E., Schumacher, K., Weimer, A., Bühling, F., Kunz, D., Lendeckel, U., Reinhold, D., Ulmer, A. J., Flad, H. -D., Ansorge, S., Bühring, Hans-Jörg, Broudy¶, Virginia C., Ashman§, Leonie K., Burk, M., Kunecke, H., Dumont, C., Meckenstock, G., Volmer, M., Bucher, M., Manegold, C., Krenpien, B., Fischer, J. R., Drings, P., Bückner, U., Donhuijsen-Ant, R., Eberhardt, B., Westerhausen, M., Busch, F. W., Jaschonek, K., Steinke, B., Calavrezos, A., Hausmann, K., Solbach, M., Woitowitz, H. -P., Hilierdal, G., Heilmann, H. -P., Chen, Z. J., Frickhofen, N., Ellbrück, D., Schwarz, T. F., Körner, K., Wiest, C., Kubanek, B., Seifried, E., Claudé, R., Brücher, J., Clemens, M. R., Bublitz, K., Bieger, O., Schmid, B., Clemetson, K. J., Clemm, Ch., Bamberg, M., Gerl, A., Weißbach, L., Danhauser-Riedl, S., Schick, H. D., Bender, R., Reuter, M., Dietzfelbinger, H., Rastetter, J., Hanauske, A. -R., Decker, Hans-Jochen, Klauck, Sabine, Seizinger, Bernd, Denfeld, Ralf, Pohl, Christoph, Renner, Christoph, Hombach, Andreas, Jung, Wolfram, Schwonzen, Martin, Pfreundschuh, Michael, Derigs, H. Günter, Boswell, H. Scott, Kühn, D., Zafferani, M., Ehrhardt, R., Fischer, K., Schmitt, M., Witt, B., Ho, A. D., Haas, R., Hunstein, W., Dölken, G., Finke, J., Lange, W., Held, M., Schalipp, E., Fauser, A. A., Mertelsmann, R., Donhuijsen, K., Nabavi, D., Leder, L. D., Haedicke, Ch., Freund, H., Hattenberger, S., Dreger, Peter, Grelle, Karen, Schmitz, Norbert, Suttorp, Meinolf, Müller-Ruchholtz, Wolfgang, Löffler, Helmut, Dumoulin, F. L., Jakschies, D., Walther, M., Hunger, P., Deicher, H., von Wussow, P., Dutcher, J. P., Ebell, W., Bender-Götze, C., Bettoni, C., Niethammer, D., Reiter, A., Sauter, S., Schrappe, M., Riehm, H., Niederle, N., Heidersdorf, H., Müller, M. R., Mengelkoch, B., Vanhoefer, U., Stahl, M., Budach, V., loehren, B., Alberti, W., Nowrousian, M. R., Seeber, S., Wilke, H., Stamatis, G., Greschuchna, D., Sack, H., Konietzko, N., Krause, B., Dopfer, R., Schmidt, H., Einsele, H., Müller, C. A., Goldmann, S. F., Grosse-Wilde, H., Waller, H. D., Libal, B., Hohaus, S., Gericke, G., von Eiff, M., Oehme, A., Roth, B., van de Loo, J., von Eiff, K., Pötter, R., Weiß, H., Suhr, B., Koch, P., Roos, H., van de Loo, J., Meuter, V., Heissig, B., Schick, F., Duda, S., Saal, J. G., Klein, R., Steidle, M., Eisner, S., Ganser, A., Seipelt, G., Leonhardt, M., Engelhard, M., Brittinger, G., Gerhartz, H., Meusers, P., Aydemir, Ü., Tintrup, W., Tiemann, H., Lennert, K., Esser, B., Hirsch, F. W., Evers, C., Riess, H., Lübbe, A., Greil, R., Köchling, A., Digel, D., Bross, K. J., Dölken, G., Mertelsmann, R., Gencic S., Ostermann, M., Baum, R. P., Fiebig, H. H., Berger, D. P., Dengler, W. A., Winterhalter, B. R., Hendriks, H., Schwartsmann, G., Pinedo, H. M., Ternes, P., Mertelsmann, R., Dölken, G., Fischbach, W., Zidianakis, Z., Lüke, G., Kirchner, Th., Mössner, J., Fischer, Thomas, Haque, Saikh J., Kumar, Aseem, Rutherford, Michael N., Williams, Bryan R. G., Flohr, T., Decker, T., Thews, A., Hild, F., Dohmen, M., von Wussow, P., Grote-Metke, A., Otremba, B., Fonatsch, C., Binder, T., Imhof, C., Feller, A. C., Fruehauf, S., Moehle, R., Hiddemann Th., Büchner M. Unterhalt, Wörmann, B., Ottmann, O. G., Verbeek, G. W., Seipelt A. Maurer, Geissler, G., Schardt, C., Reutzel, R., Hiddemann, W., Maurer, A., Hess, U., Lindemann, A., Frisch, J., Schulz, G., Mertelsmann, R., Hoelzer, P., Gassmann, W., Sperling, C., Uharek, L., Becher, R., Weh, H. J., Tirier, C., Hagemann, F. G., Fuhr, H. G., Wandt, H., Sauerland, M. C., Gause, A., Spickermann, D., Klein, S., Pfreund-schuh, M., Gebauer, W., Fallgren-Gebauer, E., Geissler, R. G., Mentzel, U., Kleiner, K., Rossol, R., Guba, P., Kojouharoff, G., Gerdau, St., Körholz, D., Klein-Vehne, A., Burdach, St., Gerdemann M., Maurer J., Gerhartz, H. H., Schmetzer, H., Mayer, P., Clemm, C., Hentrich, M., Hartenstein, R., Kohl, P., Gieseler, F., Boege, F., Enttmann, R., Meyer, P., Glass, B., Zeis, M., Loeffler, H., Mueller-Ruchholtz, W., Görg, C., Schwerk, W. B., Köppler, H., Havemann, K., Goldschmitt, J., Goldschmidt, H., Nicolai, M., Richter, Th., Blau, W., Hahn, U., Kappe, R., Leithäuser, F., Gottstein, Claudia, Schön, Gisela, Dünnebacke, Markus, Berthold, Frank, Gramatzki, M., Eger, G., Geiger, M., Burger, R., Zölch, A., Bair, H. J., Becker, W., Griesinger, F., Elfers, H., Griesser, H., Grundner-Culemann, E., Neubauer, V., Fricke, D., Shalitin, C., Benter, T., Mertelsmann, R., Dölken, Gottfried, Mertelsmann, Roland, Günther, W., Schunmm, M., Rieber, P., Thierfelder, S., Gunsilius, E., Kirstein, O., Bommer, M., Serve, H., Hülser, P. -J., Del Valle F., Fischer J. Th., Huberts H., Kaplan E., Haase, D., Halbmayer, W. -M., Feichtinger, Ch., Rubi, K., Fischer, M., Hallek, M., Lepislo, E. M., Griffin, J. D., Emst, T. J., Druker, B., Eder, M., Okuda, K., D.Griffin, J., Kozłowska-Skrzypczak, K., Meyer, B., Reile, D., Scharnofske, M., Hapke, G., Aulenbacher, P., Havemann, K., Becker, N., Scheller, S., Zugmaier, G., Pralle, H., Wahrendorf, J., Heide, Immo, Thiede, Christian, de Kant, Eric, Neubauer, Andreas, Herrmann, Richard, Rochlitz, Christoph, Heiden, B., Depenbrock, H., Block, T., Vogelsang, H., Schneider, P., Fellbaum, Ch., Heidtmann, H. -H., Blings, B., Havemann, K., Fackler-Schwalbe, E., Schlimok, G., Lösch, A., Queißer, W., Löffler, B., Kurrle, E., Chadid, L., Lindemann, A., Mertelsmann, R., Nicolay, U., Gaus, W., Heinemann, V., Jehn, U., Gleixner, B., Wachholz, W., Scholz, P., Plunkett, W., Heinze, B., Novotny, J., Hess, Georg, Gamm, Heinold, Seliger, Barbara, Heuft, H. G., Oettle, H., Zeiler, T., Eckstein, R., Heymanns, J., Havemann, K., Hladik, F., Hoang-Vu, C., Horn, R., Cetin, Y., Scheumann, G., Dralle, H., Köhrle, J., von zur Mühlen, A., Brabant, G., Hochhaus, A., Mende, S., Simon, M., Fonatsch, Ch., Heinze, B., Georgii, A., Hötzl, Ch., Hintermeier-Knabe, R., Kempeni, J., Kaul, M., Hoetzl, Ch., Clemm, Ch., Lauter, H., Hoffknecht, M. M., Eckardt, N., Hoffmann-Fezer, G., Gall, C., Kranz, B., Zengerle, U., Pfoersich, M., Birkenstock, U., Pittenann, E., Heinz, B., Hosten, N., Schörner, W., Kirsch, A., Neumann, K., Felix, R., Humpe, A., Kiss, T., Trümper, L. H., Messner, H. A., Hundt, M., Zielinska-Skowronek, M., Schubert, J., Schmidt, R. E., Huss, R., Storb, R., Deeg, H. J., Issels, R. D., Bosse, D., Abdel-Rahman, S., Jaeger, M., Söhngen, D., Weidmann, E., Schwulera, U., Jakab, I., Fodor, F., Pecze, K., Jaques, G., Schöneberger, H. -J., Wegmann, B., Grüber, A., Bust, K., Pflüger, K. -H., Havemann, K., Faul, C., Wannke, B., Scheurlen, M., Kirchner, M., Dahl, G., Schmits, R., Fohl, C., Kaiser, U., Tuohimaa, P., Wollmer, E., Aumüller, G., Havemann, K., Kolbabek, H., Schölten, C., Popov-Kraupp, B., Emminger, W., Hummel, M., Pawlita, M., v.Kalle, C., Dallenbach, F., Stein, H., Krueger, G. R. F., Müller-Lantzsch, N., Kath, R., Höffken, K., Horn, G., Brockmann, P., Keilholz, U., Stoelben, E., Scheibenbogen, C., Manasterski, M., Tilgen, W., Schlag, P., Görich, J., Kauffmann, G. W., Kempter, B., Rüth, S., Lohse, P., Khalil, R. M., Hültner, L., Mailhammer, R., Luz, A., Hasslinger, M. -A., Omran, S., Dörmer, P., Kienast, J., Kister, K. P., Seifarth, W., Klaassen, U., Werk, S., Reiter, W. W., Klein, G., Beck-Gessert, S., Timpl, R., Hinrichs, H., Lux, E., Döring, G., Scheinichen, D., Döring, G., Wernet, P., Vogeley, K. T., Richartz, G., Südhoff, T., Horstkotte, D., Klocker, J., Trotsenburg, M. v., Schumer, J., Kanatschnig, M., Henning, K., Knauf, W. U., Pottgießer, E., Raghavachar, A., Zeigmeister, B., Bollow, M., Schilling, A., König, H., Koch, M., Volkenandt, M., Seger, Andrea, Banerjee, D., Vogel, J., Bierhoff, E., Heidi, G., Neyses, L., Bertino, J., Kocki, J., Rozynkowa, D. M., M.Rupniewska, Z., Wojcierowski, J., König, V., Hopf, U., Koenigsmann, M., Streit, M., Koeppen, K. M., Martini, I., Poppy, U., Hardel, M., Havemann, K., Havemann, K., Clemm, Ch., Wendt, Th., Gauss, J., Kreienberg, R., Hohenfellner, R., Krieger, O., Istvan, L., Komarnicki, M., Kazmierczak, M., Haertle, D., Korossy, P., Haus, S. Kotlarek, Gabryś, K., Kuliszkiewicz-Janus, M., Krauter, J., Westphal, C., Werner, K., Lang, P., Preissner, K. T., Völler, H., Schröder, K., Uhrig, A., Behles, Ch., Seibt-Jung, H., Besserer, A., Kreutzmann, H., Kröning, H., Kähne, T., Eßbach, U., Kühne, W., Krüger, W. H., Krause, K., Nowicki, B., Stockschläder, M., Peters, S. O., Zander, A. R., Kurowski, V., Schüler, C., Höher, D., Montenarh, M., Lang, W., Schweiger, H., Dölken, Gottfried, Lege, H., Dölken, G., Wex, Th., Frank, K., Hastka, J., Bohrer, M., Leo, R., Peest, D., Tschechne, B., Atzpodien, J., Kirchner, H., Hein, R., Hoffmann, L., Stauch, M., Franks, C. R., Palmer, P. A., Licht, T., Mertelsmann, R., Liersch, T., Vehmeyer, K., Kaboth, U., Maschmeyer, G., Meyer, P., Helmerking, M., Schmitt, J., Adam, D., Prahst, A., Hübner, G., Meisner, M., Seifert, M., Richard, D., Yver, A., Spiekermann, K., Brinkmann, L., Battmer, K., Krainer, M., Löffel, J., Stahl, H., Wust, P., Lübbert, M., Schottelius, A., Mertelsmann, R., Henschler, R., Mertelsmann, R., Mapara, M. Y., Bargou, R., Zugck, C., Krammer, P. H., Dörken, B., Maschek, Hansjörg, Kaloutsi, Vassiliki, Maschek, Hansjörg, Gormitz, Ralf, Meyer, P., Kuntz, B. M. E., Mehl, B., Günther, I., Bülzebruck, H., Menssen, H. D., Mergenthaler, H. -G., Dörmer, P., Heusers, P., Zeller, K. -P., Enzinger, H. M., Neugebauer, T., Klippstein, T., Burkhardt, K. L., Putzicha, E., Möller, Peter, Henne, Christof, Eichelmann, Anette, Brüderlein, Silke, Dhein, Jens, Möstl, M., Krieger, O., Mucke, H., Schinkinger, M., Moiling, J., Daoud, A., Willgeroth, Ch., Mross K., Bewermeier P., Krüger W., Peters S., Berger C., Bohn, C., Edler, L., Jonat, W., Queisser, W., Heidemann, E., Goebel, M., Hamm, K., Markovic-Lipkovski, J., Bitzer, G., Müller, H., Oethinger, M., Grießhammer, M., Tuner, I., Musch E., Malek, M., Peter-Katalinic, J., Hügl, E., Helli, A., Slanicka, M., Filipowicz, A., Nissen, C., Speck, B., Nehls, M. C., Grass, H. -J., Dierbach, H., Mertelsmann, R., Thaller, J., Fiebeler, A., Schmidt, C. A., O'Bryan, J. P., Liu, E., Ritter, M., de Kant, E., Brendel, C., He, M., Dodge, R., George, S., Davey, F., Silver, R., Schiffer, C., Mayer, R., Ball, E., Bloomfield, C., Ramschak, H., Tiran, A., Truschnig-Wilders, M., Nizze, H., Bühring, U., Oelschlägel, U., Jermolow, M., Oertel, J., Weisbach, V., Zingsem, J., Wiens, M., Jessen, J., Osthoff, K., Timm, H., Wilborn, F., Bodak, K., Langmach, K., Bechstein, W., Blumhardt, G., Neuhaus, P., Olek, K., Ottinger, H., Kozole, G., Belka, C., Meusers, P., Hense, J., Papadileris, Stefan, Pasternak, G., Pasternak, L., Karsten, U., Pecherstorfer, M., Zimmer-Roth, I., Poloskey, A., Petrasch, S., Kühnemund, O., Uppenkamp, M., Lütticken, R., Kosco, M., Schmitz, J., Petrides, Petro E., Dittmann, Klaus H., Krieger, O., Pflueger, K. -H., Grueber, A., Schoeneberger, J., Wenzel, E., Havemann, K., Pies, A., Kneba, M., Edel, G., Pohl, S., Bulgay-Mörschel, M., Polzin, R., Issing, W., Clemm, Ch., Schorn, K., Ponta, H., Zöller, M., Hofmann, M., Arch, R., Heider, K. -H., Rudy, W., Tölg, C., Herrlich, P., Prümmer, O., Scherbaum, W. A., Porzsolt, F., Prümmer, O., Krüger, A., Schrezenmeier, H., Schlander, H., Pineo, G., Marin, P., Gluckman, E., Shahidi, N. T., Bacigalupo, A., Ratajczak, M. Z., Gewirtz, A. M., Ratei, R., Borner, K., Bank, U., Bühling, F., Reisbach, G., Bartke, L., Kempkes, B., Kostka, G., Ellwart, X., Birner, A., Bornkamm, G. W., Ullrich, A., Dörmer, P., Henze, G., Parwaresch, R., Müller-Weihrich, S. T., Klingebiel, Th., Odenwald, E., Brandhorst, D., Tsuruo, T., Wetter, O., Renner, C., Pohl, C., Sahin, U., Renner, U., Zeller, K. -P., Repp, R., Valerius, Th., Sendler, A., Kalden, J. R., PIatzer, E., Reuss-Borst, M. A., Bühring, H. J., Reuter, C., der Landwehr, II, U. Auf, der Landwehr, II, U. Auf, Schleyer, E., Rolf, C., Ridwelski, K., Matthias, M., Preiss, R., Riewald, M., Puzo, A., Serke, S., Rohrer, B., Pfeiffer, D., Hepp, H., Romanowski, R., Schött, C., Rüther, U., Rothe, B., Pöllmann, H., Nunnensiek, C., Schöllhammer, T., Ulshöfer, Th., Bader, H., Jipp, P., Müller, H. A. G., Rupp, W., Lüthgens, M., Eisenberger, F., Afflerbach, C., Höller, A., Schwamborn, J. S., Daus, H., Krämer, K., Pees, H., Salat, C., Reinhardt, B., Düll, T., Knabe, H., Hiller, E., Sawinski, K., Schalhorn, A., Kühl, M., Heil, K., Schardt, Ch., Drexler, H. G., Scharf, R. E., Suhijar, D., del Zoppo, G. J., Ruggeri, Z. M., Roll, T., Möhler, T., Giselinger, H., Knäbl, P., Kyrie, P. A., Lazcíka, K., Lechner, X., Scheulen, M. E., Beelen, D. W., Reithmayer, H., Daniels, R., Weiherich, A., Quabeck, K., Schaefer, U. W., Reinhardt J., Grimm M., Unterhalt M., Schliesser, G., Lohmeyer, J., Schlingheider, O., von Eiff, M., Schulze, F., Oehme, C., van de Loo, J., Schlögl E., Bemhart M., Schmeiser, Th., Rozdzinski, E., Kern, W., Reichle, A., Moritz, T., Merk, Bruno, Schmid, R. M., Perkins, N. D., Duckett, C. S., Leung, K., Nabel, G. J., Pawlaczyk-Peter, B., Kellermann-Kegreiß, Schmidt E., Steiert, I., Schmidt-Wolf, G., Schmidt-Wolf, I. G. H., Schlegel, P., Blume, K. G., Chao, N. J., Lefterova, P., Laser, J., Schmitz, G., Rothe, G., Schönfeld, S., Schulz, S., Nyce, J. W., Graf, N., Ludwig, R., Steinhauser, I., Brommer, A. E., Qui, H., Schroeder, M., Grote-Kiehn, J., Bückner, U., Rüger, I., Schröder, J., Meusers, P., Weimar, Ch., Schoch, C., Schröter, G., Stern, H., Buchwald, B., Schick, K., Avril, N., Flierdt, E. v. d., Langhammer, H. R., Pabst, H. W., Alvarado, M., Witte, T., Vogt, H., Schuler, U., Brammer, K., Klann, R. C., Schumm, M., Hahn, J., Günther, W., Wullich, B., Moringlane, J. R., Schöndorf, S., Schwartz, S., Bühring, H. -J., Notter, M., Böttcher, S., Martin, M., Schmid, H., Lübbe, A. S., Leib-Mösch C., Wankmüller, H., Eilbrück, D., Funke, I., Cardoso, M., Duranceyk, H., Seitz, R., Rappe, N., Kraus, H., Egbring, R., Haasberg, M., Havemann, K., Seibach, J., Wollscheid, Ursula, Serke, St., Zimmermann, R., Shirai, T., Umeda, M., Anno, S., Kosuge, T., Katoh, M., Moro, S., Su, C. -Y., Shikoshi, K., Arai, N., Schwieder, G., Silling-Engelhardt, G., Zühlsdorf, M., Aguion-Freire-Innig, E., van de Loo, J., Stockdreher, K., Gatsch, L., Tischler, H. -J., Ringe, B., Diedrich, H., Franzi, A., Kruse, E., Lück, R., Trenn, G., Sykora, J., Wen, T., Fung-Leung, W. P., Mak, T. W., Brady, G., Loke, S., Cossman, J., Gascoyne, R., Mak, T., Urasinski, I., Zdziarska, B., Usnarska-Zubkiewicz, L., Kotlarek-Haus, S., Sciborskl, R., Nowosad, H., Kummer, G., Schleucher, N., Preusser, P., Niebel, W., Achterrath, W., Pott, D., Eigler, F. -W., Venook, A., Stagg, R., Frye, J., Gordon, R., Ring, E., Verschuer, U. v., Baur, F., Heit, W., Corrons, J. L. L. Vives, Vogel, M., Nekarda, H., Remy, W., Bissery, M. C., Aapro, M., Buchwald-Pospiech, A., Kaltwasser, J. P., Jacobi, V., de Vos, Sven, Asano, Yoshinobu, Voss, Harald, Knuth, Alexander, Wiedemann, G., Komischke, B., Horisberger, R., Wussow, P. v., Wanders, L., Senekowitsch, R., Strohmeyer, S., Emmerich, B., Selbach, J., Gutensohn, K., Wacker-Backhaus, G., Winkeimann, M., Send, W., Rösche, J., Weide, R., Parviz, B., Havemann, K., Weidmann, B., Henss, H., Engelhardt, R., Bernards, P., Zeidler, D., Jägerbauer, E., Colajori, E., Kerpel-Fronius, S., Weiss, A., Buchheidt, D., Döring, A., D.Saeger, H., Weissbach, L., Emmler, J., Wermes, R., Meusers, P., Flasshove, M., Skorzec, M., Käding, J., Platow, S., Winkler, Ute, Thorpe, Philip, Winter, S. F., Minna, J. D., Nestor, P. J., Johnson, B. E., Gazdar, A. F., Havemann, K., Carbone, D. P., Wit, M. de, Bittner, S., Hossfeld, D., Wittmann, G., Borchelt, M., Steinhagen-Thiessen, E., Koch, K., Brosch, T., Haas, N., Wölfel, C., Knuth, A., Wölfel, T., Safford, M., Könemann, S., Zurlutter, K., Schreiber, K., Piechotka, K., Drescher, M., Toepker, S., Terstappen, L. W. M. M., Bullerdiek, J., Jox, A., zur Hausen, H., Wolters, B., Stenzinger, W., Woźny, T., Sawiński, K., Kozłowska-Skrzypczak, M., Wussow, P. v., Hochhaus, T., Ansarl, H., Prümmer, O., Zapf, H., Thorban, S., Präuer, H., Zeller, W., Stieglitz, J. v., Dürken, M., Greenshaw, C., Kabisch, H., Reuther, C., Knabbe, C., Lippman, M., Havemann, K., Wellstein, A., Degos, L., Castaigne, S., Fenaux, P., Chomienne, C., Raza, A., Preisler, H. D., PEG Interventional Antimicrobial Strategy Study Group, Interventional Antimicrobial Strategy Study Group of the Paul Ehrlich Society (PEG), and H. Riehm for the BFM study group
- Published
- 1992
- Full Text
- View/download PDF
13. Erhöhtes atriales natriuretisches Peptid (ANP) bei essentieller Hypertonie — Abhängigkeit vom rechtsatrialen Druckverhalten
- Author
-
Neyses, L., Nitsch, J., Tüttenberg, H. -P., Korus, H. -C., and Lüderitz, B.
- Published
- 1989
- Full Text
- View/download PDF
14. Angiotensin converting enzyme inhibition modulates cardiac fibroblast growth.
- Author
-
Grohé C, Kahlert S, Löbbert K, Neyses L, van Eickels M, Stimpel M, Vetter H, Grohé, C, Kahlert, S, Löbbert, K, Neyses, L, van Eickels, M, Stimpel, M, and Vetter, H
- Published
- 1998
- Full Text
- View/download PDF
15. Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?
- Author
-
Mamas MA, Deaton C, Rutter MK, Yuille M, Williams SG, Ray SG, New J, Gibson JM, Neyses L, Mamas, Mamas A, Deaton, Christi, Rutter, Martin K, Yuille, Martin, Williams, Simon G, Ray, Simon G, New, John, Gibson, J Martin, and Neyses, Ludwig
- Abstract
Background: A link between diabetes mellitus (DM) and heart failure (HF) has been well-recognized for more than a century. HF is also closely linked to abnormal glucose regulation (AGR) and insulin resistance (IR) in patients without DM and, similarly, these conditions commonly coexist. In epidemiological studies, each condition appears to predict the other. The prevalence of AGR/IR in HF patients without DM is significantly underrecognized and, as yet, the optimal method for screening for these abnormalities in the outpatient setting is unclear.Methods and Results: The purpose of this review is to overview the prevalence and prognostic impact of AGR and IR in HF patients without DM and discuss potential pathophysiological pathways that link these conditions with HF. The severity of glucose intolerance in patients with HF correlates with functional and clinical severity of HF and is an independent predictor of an adverse outcome. It is thought that changes in cardiac metabolism, including a switch from glucose metabolism toward fatty acid metabolism, may in part contribute to the pathophysiological processes associated with HF patients with AGR/IR.Conclusions: We discuss how pharmacological targeting of metabolic pathways in the myocardium of these patients with HF may represent novel therapeutic strategies in these at-risk patients. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
16. Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
- Author
-
Oceandy D, Pickard A, Prehar S, Zi M, Mohamed TM, Stanley PJ, Baudoin-Stanley F, Nadif R, Tommasi S, Pfeifer GP, Armesilla AL, Cartwright EJ, Neyses L, Oceandy, Delvac, Pickard, Adam, Prehar, Sukhpal, Zi, Min, Mohamed, Tamer M A, Stanley, Peter J, and Baudoin-Stanley, Florence
- Published
- 2009
- Full Text
- View/download PDF
17. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b.
- Author
-
Oceandy D, Cartwright EJ, Emerson M, Prehar S, Baudoin FM, Zi M, Alatwi N, Schuh K, Williams JC, Armesilla AL, Neyses L, Oceandy, Delvac, Cartwright, Elizabeth J, Emerson, Michael, Prehar, Sukhpal, Baudoin, Florence M, Zi, Min, Alatwi, Nasser, Venetucci, Luigi, and Schuh, Kai
- Published
- 2007
18. Targeted proteolysis sustains calcineurin activation.
- Author
-
Burkard N, Becher J, Heindl C, Neyses L, Schuh K, Ritter O, Burkard, Natalie, Becher, Jan, Heindl, Cornelia, Neyses, Ludwig, Schuh, Kai, and Ritter, Oliver
- Published
- 2005
19. The biological cascade leading to cardiac hypertrophy.
- Author
-
Neyses, L. and Pelzer, T.
- Abstract
Cardiac hypertrophy, one of the major risk factors in hypertension, is associated with a high incidence of congestive heart failure and sudden death. Despite efforts over the last 20 years, the underlying molecular mechanisims of cardiac hypertrophy are still poorly understood, thus making it difficult to develop new therapeutic strategies. A growing body of evidence suggests that cardiac hypertrophy results from mechanical stress that triggers paracrine and autocrine signal transduction pathways. Furthermore, whereas hypertrophy leads to isoform switches in some contractile proteins, increased protein synthesis is largely based on increased translational capacity. Cardiac growth under physiological as well as pathological conditions is regulated by several recently identified transcription factors. Among the factors that are capable of transmitting hypertrophic stimuli to the nucleus is the early growth response gene-1 (Egr-1). Whereas female gender is already an established cardioprotective factor in clinical trials, some very recent data indicate that oestrogens and the nuclear oestrogen receptor may directly modulate gene expression in the development of cardiac hypertrophy. Future pharmacological interventions could be directed towards modifying the nuclear signal transduction cascade involving multiple protein kinases and phosphatases. [ABSTRACT FROM PUBLISHER]
- Published
- 1995
- Full Text
- View/download PDF
20. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes.
- Author
-
Neyses, Ludwig, Nouskas, Janis, Luyken, Joachim, Fronhoffs, Stefan, Oberdorf, Silke, Pfeifer, Ulrich, Williams, R Sanders, Sukhatme, Vikas P., Vetter, Hans, Neyses, L, Nouskas, J, Luyken, J, Fronhoffs, S, Oberdorf, S, Pfeifer, U, Williams, R S, Sukhatme, V P, and Vetter, H
- Published
- 1993
- Full Text
- View/download PDF
21. Molecular biology of oncogenes and cardiovascular hypertrophy.
- Author
-
Neyses, Ludwig, Vetter, Hans, Neyses, L, and Vetter, H
- Published
- 1992
- Full Text
- View/download PDF
22. Effects of moexiprilat on oestrogen-stimulated cardiac fibroblast growth.
- Author
-
Grohé, C, Kahlert, S, Löbbert, K, Eickels, M, Stimpel, M, Vetter, H, and Neyses, L
- Published
- 1997
- Full Text
- View/download PDF
23. Altered calcium and sodium metabolism in red blood cells of hypertensive man: assessment by ion-selective electrodes.
- Author
-
Wehling, M, Vetter, W, Neyses, L, Groth, H, Boerlin, H -J, Locher, R, Siegenthaler, W, and Kuhlmann, U
- Published
- 1983
- Full Text
- View/download PDF
24. The Selective Cardiac Myosin Activator, CK-1827452, Increases Systolic Function in a Concentration-Dependent Manner in Patients with Stable Heart Failure (10/8/08)
- Author
-
Cleland, J.G.F., Nifontov, E.M., McMurray, J.J.V., Senior, R., Lang, C.C., Clarke, C.P., Francis, D., Greenberg, B., Mayet, J., Monaghan, M., Neyses, L., Tsyrlin, V.A., Goldman, J.H., Teerlink, J.R., Brand, G., Lee, J.H., Saikali, K.G., Wolff, A.A., and Malik, F.I.
- Published
- 2008
- Full Text
- View/download PDF
25. Extensive catheter-induced aortic dissection
- Author
-
Mamas, M.A., Alonso, A., and Neyses, L.
- Published
- 2008
- Full Text
- View/download PDF
26. Alpha 7 integrin is essential for normal heart shape and function
- Author
-
Nadif-Savey, R., Emerson, M., Cartwright, E.J., Mayer, U., and Neyses, L.
- Published
- 2006
- Full Text
- View/download PDF
27. Hormonal induction of an immediate–early gene response in myogenic cell lines—a paradigm for heart growth.
- Author
-
Maass, A., Grohé, C., Kubisch, C., Wollnik, B., Vetter, H., and Neyses, L.
- Abstract
Cardiac hypertrophy is characterized by growth of myocardial cells without proliferation. Many endo- paracrine stimuli such as angiotensin II, endothelin, aradrenergic agonists, and insulin have been shown to be able to induce cardiac hypertrophy either in vivo or in vitro. We have used the myoblast model of differentiation and proliferation to determine nuclear signal transduction mechanisms in muscle and (by analogy) cardiac growth. The first nuclear event known to occur when a growth stimulus acts upon a cell is induction of a family of immediate-early genes. Our group focused on the role of one of these genes, the early growth response gene-1 (Egr-1). We have shown that this gene is induced in isolated adult cardiac myocytes in the presence of endothelin. An anti-sense oligonucleotide complementary to the first six codons of the Egr-1 mRNA abolishes the stimulation of protein synthesis induced by endothelin. In the present study we further characterized paracrine growth stimuli in the myogenic cell line Sol8, which was used as a paradigm to further investigate mechanisms of paracrine growth induction. We demonstrated that a variety of candidate endo- paracrine stimuli for the induction of cardiac hypertrophy induced the Egr-1 messenger RNA in the myogenic cell line Sol8. Among these are endothelin, insulin, basic fibroblast growth factor, and platelet-derived growth factor BB (PDGE BB). We conclude: (1) In analogy to the myocardium, these growth factors act upon myoblasts. (2) This line appears to be a suitable model for the molecular characterization of Egr-1 target genes. [ABSTRACT FROM PUBLISHER]
- Published
- 1995
- Full Text
- View/download PDF
28. Sequence analysis of polymerase chain reaction amplified t(14;18) chromosomal breakpoints in formalin fixed, paraffin wax embedded follicular lymphoma.
- Author
-
Volkenandt, M, Koch, O, Fanin, R, Banerjee, D, Seger, A, Vogel, J, Bierhoff, E, Heidl, G, Neyses, L, and Bertino, J R
- Abstract
AIMS: To determine whether junctional sequences of rearranged chromosomes can be amplified by use of the polymerase chain reaction (PCR) and whether direct sequence analysis of the PCR products is possible, using DNA from formalin fixed, paraffin wax embedded biopsy specimens. METHODS: DNA was extracted from paraffin wax embedded, formalin fixed lymphoma specimens, and junctional sequences of rearranged chromosomes were amplified by the PCR. The products were used as templates for asymmetrical PCR. Subsequently, direct sequence analysis was performed using the chain termination method. RESULTS: Formalin fixed, paraffin wax embedded biopsy specimens and PCR amplification could be used to determine the nucleotide sequences of junctional regions of rearranged chromosomes t(14;18) from patients with follicular lymphoma. CONCLUSION: The identification of junctional sequences of the translocation in follicular lymphoma provides a molecular "fingerprint" of t(14;18) of the lymphoma of an individual patient and can be used for the detection of clone specific DNA in any biopsy tissue obtained from the patient. The strategy used for rapid sequence analysis of PCR amplified DNA sequences will be useful in many areas of molecular pathology. [ABSTRACT FROM PUBLISHER]
- Published
- 1992
29. First clinical trial of the selective cardiac myosin activator, CK-1827452, in Heart Failure: effect of dose and plasma concentration on systolic function
- Author
-
Cleland, J.G.F., McMurray, J.J., Lang, C.C., Clarke, C.P., Neyses, L., Saikali, K.G., Lee, J.H., Goldman, J., Teerlink, J.R., and Malik, F.I.
- Subjects
MYOSIN ,HEART failure treatment - Abstract
An abstract of the article "First clinical trial of the selective cardiac myosin activator, CK-1827452, in Heart Failure: effect of dose and plasma concentration on systolic function," by J. G. F. Cleland and colleagues is presented.
- Published
- 2008
- Full Text
- View/download PDF
30. 277 Stimulation of myocardial AT2-rezeptors increases calcineurin activity via calpain
- Author
-
Ritter, O., Schuh, K., and Neyses, L.
- Subjects
CALCINEURIN ,CALPAIN - Abstract
An abstract of the article "Stimulation of Myocardial AT2-Rezeptors Increases Calcineurin Activity Via Calpain," by O. Ritter and colleagues is presented.
- Published
- 2004
31. 38 Use of Sodium/Potassium Chloride Mixtures.
- Author
-
Neyses, L, Groth, H, Greminger, P, Bucher, Y, Siegenthaler, W, and Vetter, W
- Published
- 1984
- Full Text
- View/download PDF
32. P77 Specific consideration when interpreting the hypertrophy response to pressure overload in C57BL/6NTac and C57BL/6J mice.
- Author
-
Zi, M, Stafford, N, Prehar, S, Shaheen, M, Oceandy, D, Neyses, L, and Cartwright, E
- Subjects
CARDIAC hypertrophy ,LABORATORY mice ,CONSORTIA ,ECHOCARDIOGRAPHY ,STIMULUS & response (Biology) ,HEART cells - Abstract
Purpose: Transverse aortic constriction (TAC) has been extensively used as a cardiac stress in genetically modified mice to investigate the molecular mechanisms of cardiac hypertrophy. But the hypertrophic response to TAC can be significantly influenced by the time course of TAC, the age and the genetic background of the mice. The International Knockout Mouse Consortium has selected to use the C57BL/6NTac mouse strain to generate null alleles for all mouse genes; however, we have found a range of baseline cardiac phenotypic differences between this substrain and the commonly used C57BL/6J substrain. Therefore, we have assessed the optimal conditions to induce cardiac hypertrophy by TAC in the C57BL/6NTac strain, and have determined whether the hypertrophic response to TAC is different in these two C57BL/6 substrains.Methods: To establish the optimal conditions for TAC-induced hypertrophy in the C57BL/6NTac substrain, 8, 10 and 12-week old mice were subjected to TAC and monitored by echocardiography. Cardiac function was found to significantly deteriorate in 10-12 week old mice after 2 weeks, while 8-week old mice developed hypertrophy after 2 weeks and then reduced cardiac function after 5 weeks. Therefore, 2-week TAC in 8 week old mice was used to further study the hypertrophic response in the two C57BL/6 substrains. Echocardiography, conscious ECG, cardiac haemodynamic assessment, histology, and real-time PCR were conducted to evaluate cardiac function, hypertrophy, fibrosis, and the expression of hypertrophy markers.Results: Cardiac hypertrophy evaluated by heart weight to tibia length ratio (HW/TL) was highly variable in C57BL/6J mice, but this reflected the variation in aortic arch dimension as assessed by echocardiography. When comparing the response to the hypertrophic stimulus, C57BL/6NTac demonstrated greater hypertrophic growth as evaluated by HW/TL, cardiomyocyte cell surface area, and expression of BNP (all p<0.05). Cardiac remodelling such as fibrosis was also more extensive. This exacerbated hypertrophic growth was associated with increased QRS duration (19.33±2.76 vs. 15.29±0.64 ms, p=0.01), QTc interval and multiple ventricular arrhythmias in C57BL/6NTac mice.Conclusion: There are clear differences in the response to pressure overload in widely used C57BL/6 substrains. C57BL/6J mice were found to have a large variation in aortic structure which is reflected in the variable hypertrophic response; whilst the C57BL/6NTac substrain has a consistently exacerbated hypertrophic response. It is therefore essential to consider these distinct phenotypic differences when interpreting data. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
33. P89 Understanding barriers and enablers of physical activity among patients with heart failure: a systematic review of qualitative studies.
- Author
-
Tierney, S., Deaton, C., Mamas, M., Rutter, M., Gibson, M., and Neyses, L.
- Subjects
HEART failure treatment ,EXERCISE therapy ,SYSTEMATIC reviews ,QUALITATIVE research ,SOCIAL learning theory ,PHYSICAL activity - Published
- 2011
- Full Text
- View/download PDF
34. 21 Physical activity as heart failure therapy: patient perspectives.
- Author
-
Tierney, S., Deaton, C., Elwers, H., Sange, C., Mamas, M., Rutter, M., Gibson, M., and Neyses, L.
- Subjects
HEART failure treatment ,HEALTH promotion ,INTERVIEWING ,RESEARCH methodology ,COMORBIDITY ,QUALITATIVE research ,JUDGMENT sampling ,PHYSICAL activity - Published
- 2011
- Full Text
- View/download PDF
35. BAS/BSCR6 α-Ketoglutarate: biological effects of a novel biomarker of heart failure.
- Author
-
Nikolaidou, T., Mamas, M., Oceandy, D., and Neyses, L.
- Subjects
HEART failure patients ,METABOLITES ,BIOMARKERS ,PEPTIDES ,HEART cells - Abstract
Heart failure is often associated with renal impairment (cardiorenal syndrome). Using a metabolomics approach, our group identified α-ketoglutarate as a novel metabolite that was significantly elevated in patients with heart failure. It was as strongly associated with heart failure as the 'gold-standard-tm) biomarker brain natriuretic peptide. α-Ketoglutarate is a citric acid cycle intermediate, central in cardiac energy production. It is the ligand of GPR99, a G-protein coupled receptor mostly expressed in the kidney. In HEK 293 cells, GPR99 acted through a Gq-mediated pathway to increase intracellular calcium. Importantly, we found that the GPR99 receptor is present in neonatal rat cardiomyocytes (NRCM). We tested the expression of 84 genes previously known as regulators of angiogenesis in NRCM treated with 1 mM α-ketoglutarate. Using real-time PCR, we found significant increase in the expression of VEGF receptor-1 and placental growth factor, suggesting a possible effect of α-ketoglutarate in the regulation of angiogenesis and growth. These findings show that binding of α-ketoglutarate to the GPR99 receptor in the heart leads to activation of the Gq pathway and causes upregulation of VEGFR1 and placental growth factor. This might have a role in vascular adaptation to hypertrophy. In addition, in vivo animal studies have previously shown that protein kinase C has a role in renal dysfunction. This leads to the novel and testable hypothesis that α-ketoglutarate also contributes to the development of the cardiorenal syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
36. BAS/BSCR3 Partial reconstruction of myocardial metabolic pathways following analysis of peripheral serum using metabolomics in early cardiac ischaemia.
- Author
-
Mamas, M. A., Dunn, W. B., Broadhurst, D., Chacko, S., Brown, M., El-Omar, M., Fath-Ordoubadi, F., Goodacre, R., Kell, D. B., and Neyses, L.
- Subjects
HEART metabolism ,HEART function tests ,ARRHYTHMIA ,FATTY acids ,PALMITIC acid ,LIPID metabolism - Abstract
Cardiac metabolism and cardiac function are inextricably linked, with changes in cardiac metabolism during cardiac ischaemia contributing to the development of cardiac arrhythmias. Using metabolomics, we aim to identify metabolite changes occurring during cardiac ischaemia through analysis of peripheral serum to reconstruct myocardial metabolic pathways that contribute to the development of cardiac arrhythmias. Peripheral venous samples from 25 patients (and 20 patients in a validation cohort) were analysed in an untargeted fashion using LC-MS following cardiac ischaemia induced by transient coronary artery occlusion during PCI at baseline, 1 and 5 min. Following validation, 99 and 126 metabolite peaks were significantly different at 1 min and 5 min after coronary occlusion compared with baseline (p<0.05). Predominantly metabolic pathways involving lipids were perturbed with changes in diacylglycerols (DG), lysophophatidylcholines (LPC), phosphatidylcholine (PC) and free fatty acids (FFA). Myocardial metabolic pathways involving the synthesis of PC from DG and their subsequent breakdown by phospholipase A2 into LPC and FFA such as arachidonic acid (AA) stimulating the oxidation of adrenaline to form the arrhythmogenic metabolite adrenochrome were reconstructed. We are able to reconstruct metabolic pathways involving lipid metabolism within the myocardium during cardiac ischaemia through analysis of the peripheral serum using metabolomics. Our unbiased approach has identified metabolic pathways involved in the production and release of metabolites with pro-arrhythmic properties (AA, LPC and adrenochrome) and metabolites with anti-arrhythmic properties (omega-3 fatty acids: eicosapentaenoic and docosahexanoic acid). This suggests that arrhythmogenesis may be a delicate balance between the endogenous formation of pro-arrhythmic and anti-arrhythmic metabolites. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
37. A Meta-Analysis of CRT in patients with heart failure and the development of atrial fibrillation
- Author
-
Mamas, M., Contractor, H., Fath-Ordoubadi, F., Garratt, C., Neyses, L., and Caldwell, J.
- Subjects
HEART failure ,ATRIAL fibrillation - Abstract
An abstract of the article "A Meta-Analysis of CRT in patients with heart failure and the development of atrial fibrillation," by M. Mamas and colleagues is presented.
- Published
- 2008
- Full Text
- View/download PDF
38. Burden of asymptomatic episodes of atrial fibrillation in a heart failure cohort
- Author
-
Caldwell, J.C., Contractor, H., Garratt, C.J., Neyses, L., and Mamas, M.
- Subjects
ATRIAL fibrillation ,HEART failure patients - Abstract
An abstract of the article "Burden of asymptomatic episodes of atrial fibrillation in a heart failure cohort," by J.C. Caldwell and colleagues is presented.
- Published
- 2008
- Full Text
- View/download PDF
39. 355 Plasma membrane calcium ATPase isoform 4 as a potential drug target for treatment during hypertrophy
- Author
-
Cartwright, E., Baudoin, F., Oceandy, D., Prehar, S., Zi, M., and Neyses, L.
- Subjects
HYPERTROPHY ,ADENOSINE triphosphatase - Abstract
An abstract of the article "Plasma Membrane Calcium ATPase Isoform 4 As a Potential Drug Target for Treatment During Hypertrophy," by E. Cartwright and colleagues is presented.
- Published
- 2007
- Full Text
- View/download PDF
40. 185 Abnormal electrical function of the heart caused by loss of integrin alpha7gene
- Author
-
Nadif-Savey, R., Cartwright, E.J., Emerson, M., Guo, C., Mayer, U., and Neyses, L.
- Subjects
INTEGRINS - Abstract
An abstract of the article "Abnormal Electrical Function of the Heart Caused by Loss of Integrin Alpha 7 Gene," by E. J. Nadif-Savey and colleagues is presented.
- Published
- 2007
- Full Text
- View/download PDF
41. 110 The promoter activity of matrix metalloproteinase-3 gene is associated with left ventricular remodelling and regurgitation in Mitral Valve Prolapse patients
- Author
-
Oceandy, D., Yussoff, R., Ray, S.G., Baudoin, F.M., and Neyses, L.
- Subjects
MATRIX metalloproteinases ,MITRAL valve prolapse - Abstract
An abstract of the study "The Promoter Activity of Matrix Metalloproteinase-3 Gene Is Associated With Left Ventricular Remodelling and Regurgitation in Mitral Valve Prolapse Patients," by L. Neyses and colleagues is presented.
- Published
- 2007
- Full Text
- View/download PDF
42. 536 The effect of diuretics on peak oxygen consumption and quality of life in patients with compensated left ventricular dysfunction
- Author
-
Gupta, S., Waywell, C., Clayton, P., Gandhi, N., Coppinger, T., Brooks, N.H., and Neyses, L.
- Subjects
DIURETICS ,HEART ventricle diseases - Abstract
An abstract of the study "The Effect of Diuretics on Peak Oxygen Consumption and Quality of Life in Patients With Compensated Left Ventricular Dysfunction," by S. Gupta and colleagues is presented.
- Published
- 2006
- Full Text
- View/download PDF
43. 99 The −1171 5A/6A polymorphism of matrix metalloproteinase 3 gene predicts regurgitation and left ventricular remodelling in mitral valve prolapse patients
- Author
-
Oceandy, D., Yusoff, R., Ray, S.G., and Neyses, L.
- Subjects
METALLOPROTEINASES ,MITRAL valve prolapse - Abstract
An abstract of the study "The -1171 5A/6A polymorphism of matrix metalloproteinase 3 gene predicts regurgitation and left ventricular remodelling in mitral valve prolapse patients," by D. Oceandy and colleagues is presented.
- Published
- 2006
- Full Text
- View/download PDF
44. 31 Nifedipine in Hypertensive Emergencies and Severe Hypertension.
- Author
-
Groth, H, Förster, E C, Neyses, L, Siegenthaler, W, and Vetter, W
- Published
- 1984
- Full Text
- View/download PDF
45. Perturbations in cardiac metabolism in a human model of acute myocardial ischaemia.
- Author
-
Chacko S, Mamas MA, El-Omar M, Simon D, Haseeb S, Fath-Ordoubadi F, Clarke B, Neyses L, and Dunn WB
- Subjects
- Humans, Metabolome, Metabolomics, Coronary Artery Disease, Coronary Occlusion, Percutaneous Coronary Intervention
- Abstract
Introduction: Acute myocardial ischaemia and the transition from reversible to irreversible myocardial injury are associated with abnormal metabolic patterns. Advances in metabolomics have extended our capabilities to define these metabolic perturbations on a metabolome-wide scale., Objectives: This study was designed to identify cardiac metabolic changes in serum during the first 5 min following early myocardial ischaemia in humans, applying an untargeted metabolomics approach., Methods: Peripheral venous samples were collected from 46 patients in a discovery study (DS) and a validation study (VS) (25 for DS, 21 for VS). Coronary sinus venous samples were collected from 7 patients (4 for DS, 3 for VS). Acute myocardial ischaemia was induced by transient coronary occlusion during percutaneous coronary intervention (PCI). Plasma samples were collected at baseline (prior to PCI) and at 1 and 5 min post-coronary occlusion. Samples were analyzed by Ultra Performance Liquid Chromatography-Mass Spectrometry in an untargeted metabolomics approach., Results: The study observed changes in the circulating levels of metabolites at 1 and 5 min following transient coronary ischaemia. Both DS and VS identified 54 and 55 metabolites as significant (P < 0.05) when compared to baseline levels, respectively. Fatty acid beta-oxidation and anaerobic respiration, lysoglycerophospholipids, arachidonic acid, docosahexaenoic acid, tryptophan metabolism and sphingosine-1-phosphate were identified as mechanistically important., Conclusion: Using an untargeted metabolomics approach, the study identified important cardiac metabolic changes in peripheral and coronary sinus plasma, in a human model of controlled acute myocardial ischaemia. Distinct classes of metabolites were shown to be involved in the rapid cardiac response to ischemia and provide insights into diagnostic and interventional targets., (© 2021. Crown.)
- Published
- 2021
- Full Text
- View/download PDF
46. PMCA4 inhibition does not affect cardiac remodelling following myocardial infarction, but may reduce susceptibility to arrhythmia.
- Author
-
Stafford N, Zi M, Baudoin F, Mohamed TMA, Prehar S, De Giorgio D, Cartwright EJ, Latini R, Neyses L, and Oceandy D
- Subjects
- Animals, Arrhythmias, Cardiac physiopathology, Arrhythmias, Cardiac prevention & control, Calcium-Transporting ATPases genetics, Disease Models, Animal, Female, Fibroblasts metabolism, Heart Failure physiopathology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocardial Infarction metabolism, Myocardium metabolism, Myocytes, Cardiac metabolism, Plasma Membrane Calcium-Transporting ATPases genetics, Plasma Membrane Calcium-Transporting ATPases metabolism, Vascular Remodeling genetics, Vascular Remodeling physiology, Ventricular Remodeling genetics, Ventricular Remodeling physiology, Arrhythmias, Cardiac genetics, Calcium-Transporting ATPases metabolism, Myocardial Infarction genetics
- Abstract
Ischaemic heart disease is the world's leading cause of mortality. Survival rates from acute myocardial infarction (MI) have improved in recent years; however, this has led to an increase in the prevalence of heart failure (HF) due to chronic remodelling of the infarcted myocardium, for which treatment options remain poor. We have previously shown that inhibition of isoform 4 of the plasma membrane calcium ATPase (PMCA4) prevents chronic remodelling and HF development during pressure overload, through fibroblast mediated Wnt signalling modulation. Given that Wnt signalling also plays a prominent role during remodelling of the infarcted heart, this study investigated the effect of genetic and functional loss of PMCA4 on cardiac outcomes following MI. Neither genetic deletion nor pharmacological inhibition of PMCA4 affected chronic remodelling of the post-MI myocardium. This was the case when PMCA4 was deleted globally, or specifically from cardiomyocytes or fibroblasts. PMCA4-ablated hearts were however less prone to acute arrhythmic events, which may offer a slight survival benefit. Overall, this study demonstrates that PMCA4 inhibition does not affect chronic outcomes following MI.
- Published
- 2021
- Full Text
- View/download PDF
47. Cardiac hypertrophy or failure? - A systematic evaluation of the transverse aortic constriction model in C57BL/6NTac and C57BL/6J substrains.
- Author
-
Zi M, Stafford N, Prehar S, Baudoin F, Oceandy D, Wang X, Bui T, Shaheen M, Neyses L, and Cartwright EJ
- Abstract
Background: The mouse model of transverse aortic constriction (TAC) has been widely used as a cardiac stress in the investigation of the molecular mechanisms of cardiac hypertrophy. Recently, the International Knockout Mouse Consortium has selected the C57BL/6NTac (BL/6N) mouse strain to generate null alleles for all mouse genes; however, a range of genetic and cardiac phenotypic differences have been reported between this substrain and the commonly used C57BL/6J (BL/6J) substrain. It has been reported by Garcia-Menendez and colleagues that 12-week C57BL/6NTac mice are susceptible to heart failure but little is known about the cardiac remodeling in this substrain as cardiac function progresses from compensation to decompensation., Methods: BL/6J and BL/6N mice were subjected to pressure overload via TAC. The impact of both age and duration of cardiac pressure overload induced by TAC on cardiac remodelling were systematically assessed., Results: Our data showed that BL/6N mice developed eccentric hypertrophy with age- and time-dependent deterioration in cardiac function, accompanied by considerable interstitial fibrosis. In contrast, BL/6J mice were more resilient to TAC-induced cardiac stress and developed variable cardiac phenotypes independent of age and the duration of pressure overload. This was likely due to the greater variability in pre-TAC aortic arch dimension as measured by echocardiography. In addition to increased expression of brain natriuretic peptide and collagen gene type 1 and 3, BL/6N mice also had greater angiotensin II type 2 receptor (AT2R) gene expression than BL/6J counterparts at baseline and after 2-weeks TAC, which may contribute to the exacerbated interstitial fibrosis., Conclusions: BL/6N and BL/6J mice have very different responses to TAC stimulation and these differences should be taken into consideration when using the substrains to investigate the mechanisms of hypertrophy and heart failure., Competing Interests: Authors have no conflicts of interest to disclose., (© 2019 The Authors.)
- Published
- 2019
- Full Text
- View/download PDF
48. Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism.
- Author
-
Lewis S, Little R, Baudoin F, Prehar S, Neyses L, Cartwright EJ, and Austin C
- Subjects
- Animals, Aurintricarboxylic Acid pharmacology, Calcium metabolism, Consciousness, In Vitro Techniques, Male, Mesenteric Arteries drug effects, Mice, Knockout, Models, Biological, Peptides pharmacology, Plasma Membrane Calcium-Transporting ATPases metabolism, Blood Pressure drug effects, Mesenteric Arteries physiopathology, Nitric Oxide Synthase Type I metabolism, Plasma Membrane Calcium-Transporting ATPases antagonists & inhibitors
- Abstract
Cardiovascular disease is the world's leading cause of morbidity and mortality, with high blood pressure (BP) contributing to increased severity and number of adverse outcomes. Plasma membrane calcium ATPase 4 (PMCA4) has been previously shown to modulate systemic BP. However, published data are conflicting, with both overexpression and inhibition of PMCA4 in vivo shown to increase arterial contractility. Hence, our objective was to determine the role of PMCA4 in the regulation of BP and to further understand how PMCA4 functionally regulates BP using a novel specific inhibitor to PMCA4, aurintricarboxylic acid (ATA). Our approach assessed conscious BP and contractility of resistance arteries from PMCA4 global knockout (PMCA4KO) mice compared to wild-type animals. Global ablation of PMCA4 had no significant effect on BP, arterial structure or isolated arterial contractility. ATA treatment significantly reduced BP and arterial contractility in wild-type mice but had no significant effect in PMCA4KO mice. The effect of ATAin vivo and ex vivo was abolished by the neuronal nitric oxide synthase (nNOS) inhibitor Vinyl-l-NIO. Thus, this highlights differences in the effects of PMCA4 ablation and acute inhibition on the vasculature. Importantly, for doses here used, we show the vascular effects of ATA to be specific for PMCA4 and that ATA may be a further experimental tool for elucidating the role of PMCA4., (© 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.)
- Published
- 2018
- Full Text
- View/download PDF
49. Reduced expression of PMCA1 is associated with increased blood pressure with age which is preceded by remodelling of resistance arteries.
- Author
-
Little R, Zi M, Hammad SK, Nguyen L, Njegic A, Kurusamy S, Prehar S, Armesilla AL, Neyses L, Austin C, and Cartwright EJ
- Subjects
- Aging metabolism, Animals, Blood Pressure physiology, Calcium metabolism, Gene Expression, Heterozygote, Hypertension metabolism, Hypertension physiopathology, Male, Mesenteric Arteries physiopathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Myography, Plasma Membrane Calcium-Transporting ATPases deficiency, Aging genetics, Hypertension genetics, Mesenteric Arteries metabolism, Plasma Membrane Calcium-Transporting ATPases genetics, Vascular Remodeling genetics, Vascular Resistance genetics
- Abstract
Hypertension is a well-established risk factor for adverse cardiovascular events, and older age is a risk factor for the development of hypertension. Genomewide association studies have linked ATP2B1, the gene for the plasma membrane calcium ATPase 1 (PMCA1), to blood pressure (BP) and hypertension. Here, we present the effects of reduction in the expression of PMCA1 on BP and small artery structure and function when combined with advancing age. Heterozygous PMCA1 null mice (PMCA1
Ht ) were generated and conscious BP was measured at 6 to 18 months of age. Passive and active properties of isolated small mesenteric arteries were examined by pressure myography. PMCA1Ht mice exhibited normal BP at 6 and 9 months of age but developed significantly elevated BP when compared to age-matched wild-type controls at ≥12 months of age. Decreased lumen diameter, increased wall thickness and increased wall:lumen ratio were observed in small mesenteric arteries from animals 9 months of age and older, indicative of eutrophic remodelling. Increases in mesenteric artery intrinsic tone and global intracellular calcium were evident in animals at both 6 and 18 months of age. Thus, decreased expression of PMCA1 is associated with increased BP when combined with advancing age. Changes in arterial structure precede the elevation of BP. Pathways involving PMCA1 may be a novel target for BP regulation in the elderly., (© 2017 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.)- Published
- 2017
- Full Text
- View/download PDF
50. Selective inhibition of plasma membrane calcium ATPase 4 improves angiogenesis and vascular reperfusion.
- Author
-
Kurusamy S, López-Maderuelo D, Little R, Cadagan D, Savage AM, Ihugba JC, Baggott RR, Rowther FB, Martínez-Martínez S, Arco PG, Murcott C, Wang W, Francisco Nistal J, Oceandy D, Neyses L, Wilkinson RN, Cartwright EJ, Redondo JM, and Armesilla AL
- Subjects
- Animals, Aurintricarboxylic Acid pharmacology, Calcium-Transporting ATPases genetics, Cell Membrane genetics, Cell Movement drug effects, Cell Movement physiology, Human Umbilical Vein Endothelial Cells cytology, Humans, Mice, Mice, Knockout, Neovascularization, Physiologic drug effects, Zebrafish genetics, Zebrafish Proteins genetics, Calcium-Transporting ATPases metabolism, Cell Membrane metabolism, Human Umbilical Vein Endothelial Cells metabolism, Neovascularization, Physiologic physiology, Zebrafish metabolism, Zebrafish Proteins metabolism
- Abstract
Aims: Ischaemic cardiovascular disease is a major cause of morbidity and mortality worldwide. Despite promising results from pre-clinical animal models, VEGF-based strategies for therapeutic angiogenesis have yet to achieve successful reperfusion of ischaemic tissues in patients. Failure to restore efficient VEGF activity in the ischaemic organ remains a major problem in current pro-angiogenic therapeutic approaches. Plasma membrane calcium ATPase 4 (PMCA4) negatively regulates VEGF-activated angiogenesis via inhibition of the calcineurin/NFAT signalling pathway. PMCA4 activity is inhibited by the small molecule aurintricarboxylic acid (ATA). We hypothesize that inhibition of PMCA4 with ATA might enhance VEGF-induced angiogenesis., Methods and Results: We show that inhibition of PMCA4 with ATA in endothelial cells triggers a marked increase in VEGF-activated calcineurin/NFAT signalling that translates into a strong increase in endothelial cell motility and blood vessel formation. ATA enhances VEGF-induced calcineurin signalling by disrupting the interaction between PMCA4 and calcineurin at the endothelial-cell membrane. ATA concentrations at the nanomolar range, that efficiently inhibit PMCA4, had no deleterious effect on endothelial-cell viability or zebrafish embryonic development. However, high ATA concentrations at the micromolar level impaired endothelial cell viability and tubular morphogenesis, and were associated with toxicity in zebrafish embryos. In mice undergoing experimentally-induced hindlimb ischaemia, ATA treatment significantly increased the reperfusion of post-ischaemic limbs., Conclusions: Our study provides evidence for the therapeutic potential of targeting PMCA4 to improve VEGF-based pro-angiogenic interventions. This goal will require the development of refined, highly selective versions of ATA, or the identification of novel PMCA4 inhibitors., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.